These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35739315)

  • 1. Predicting prognosis and clinical features of the tumor microenvironment based on ferroptosis score in patients with breast cancer.
    Yin L; Tang Y
    Sci Rep; 2022 Jun; 12(1):10611. PubMed ID: 35739315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of a novel ferroptosis-related gene model in breast cancer.
    Lu YJ; Gong Y; Li WJ; Zhao CY; Guo F
    Ann Transl Med; 2022 Feb; 10(4):184. PubMed ID: 35280394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer.
    He Z; Zhou Z; Wang F; Gai L; Huang Y; Zhong X; Li J; Zuo L; Zhang N; Ni S
    Ann Transl Med; 2022 Aug; 10(15):833. PubMed ID: 36035010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis heterogeneity within the tumor microenvironment revealed a genetic blueprint of breast cancer.
    Qiu Z; Deng C; Zhou F; Chen Y; Chen X; Liu X; Ye C; Jin N
    Environ Toxicol; 2024 May; 39(5):2741-2752. PubMed ID: 38251953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
    Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
    Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
    Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Jiang S; Zhang W; Zhong C
    Sci Rep; 2022 Aug; 12(1):13766. PubMed ID: 35962042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and prediction model of ferroptosis related genes in breast cancer.
    Wang L; Chen Y; Zhao J; Luo D; Tian W
    Transl Cancer Res; 2022 Jul; 11(7):1970-1976. PubMed ID: 35966288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis.
    Chen W; Kang Y; Sheng W; Huang Q; Cheng J; Pei S; Meng Y
    Front Immunol; 2024; 15():1331841. PubMed ID: 38370403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
    Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
    Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ferroptosis-related subtypes, characteristics of TME infiltration and development of prognostic models in gastric cancer.
    Tang X; Yu Y; Liu N; Su Y; Zhang K; Zhai Z; Chen C; Sun W; Chen D; Ling R
    Int Immunopharmacol; 2024 Mar; 130():111610. PubMed ID: 38402832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.